We are live on
!
Find out more
IBBJ
Defiance Nasdaq Junior Biotechnology ETF
IBBJ
IBBJ
Delisted
IBBJ was delisted on the 2nd of December, 2021.
9 hedge funds and large institutions have $887K invested in Defiance Nasdaq Junior Biotechnology ETF in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
112% more capital invested
Capital invested by funds: $418K → $887K (+$469K)
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
13% more funds holding
Funds holding: 8 → 9 (+1)
Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$231K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$19.3K |